BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chuang YH, Ridgway WM, Ueno Y, Gershwin ME. Animal models of primary biliary cirrhosis. Clin Liver Dis. 2008;12:333-47; ix. [PMID: 18456184 DOI: 10.1016/j.cld.2008.02.011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Rojas M, Restrepo-jiménez P, Monsalve DM, Pacheco Y, Acosta-ampudia Y, Ramírez-santana C, Leung PS, Ansari AA, Gershwin ME, Anaya J. Molecular mimicry and autoimmunity. Journal of Autoimmunity 2018;95:100-23. [DOI: 10.1016/j.jaut.2018.10.012] [Cited by in Crossref: 112] [Cited by in F6Publishing: 153] [Article Influence: 28.0] [Reference Citation Analysis]
2 Schrumpf E, Jiang X, Zeissig S, Pollheimer MJ, Anmarkrud JA, Tan C, Exley MA, Karlsen TH, Blumberg RS, Melum E. The role of natural killer T cells in a mouse model with spontaneous bile duct inflammation. Physiol Rep 2017;5:e13117. [PMID: 28219981 DOI: 10.14814/phy2.13117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
3 Schrumpf E, Kummen M, Valestrand L, Greiner TU, Holm K, Arulampalam V, Reims HM, Baines J, Bäckhed F, Karlsen TH, Blumberg RS, Hov JR, Melum E. The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation. J Hepatol 2017;66:382-9. [PMID: 27720803 DOI: 10.1016/j.jhep.2016.09.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
4 Fransén-Pettersson N, Duarte N, Nilsson J, Lundholm M, Mayans S, Larefalk Å, Hannibal TD, Hansen L, Schmidt-Christensen A, Ivars F, Cardell S, Palmqvist R, Rozell B, Holmberg D. A New Mouse Model That Spontaneously Develops Chronic Liver Inflammation and Fibrosis. PLoS One 2016;11:e0159850. [PMID: 27441847 DOI: 10.1371/journal.pone.0159850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
5 Dietrich CG, Götze O, Geier A. Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance. World J Gastroenterol 2016; 22(1): 72-88 [PMID: 26755861 DOI: 10.3748/wjg.v22.i1.72] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
6 Sharma D, Parameswaran N. Multifaceted role of β-arrestins in inflammation and disease. Genes Immun 2015;16:499-513. [PMID: 26378652 DOI: 10.1038/gene.2015.37] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
7 Chang CH, Chen YC, Zhang W, Leung PS, Gershwin ME, Chuang YH. Innate immunity drives the initiation of a murine model of primary biliary cirrhosis. PLoS One. 2015;10:e0121320. [PMID: 25807531 DOI: 10.1371/journal.pone.0121320] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
8 Schwinge D, Carambia A, Quaas A, Krech T, Wegscheid C, Tiegs G, Prinz I, Lohse AW, Herkel J, Schramm C. Testosterone Suppresses Hepatic Inflammation by the Downregulation of IL-17, CXCL-9, and CXCL-10 in a Mouse Model of Experimental Acute Cholangitis. J I 2015;194:2522-30. [DOI: 10.4049/jimmunol.1400076] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
9 Chang CH, Chen YC, Yu YH, Tao MH, Leung PS, Ansari AA, Gershwin ME, Chuang YH. Innate immunity drives xenobiotic-induced murine autoimmune cholangitis. Clin Exp Immunol. 2014;177:373-380. [PMID: 24547942 DOI: 10.1111/cei.12298] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
10 Kopec AK, Sullivan BP, Kassel KM, Joshi N, Luyendyk JP. Toxicogenomic analysis reveals profibrogenic effects of trichloroethylene in autoimmune-mediated cholangitis in mice. Toxicol Sci 2014;141:515-23. [PMID: 25055964 DOI: 10.1093/toxsci/kfu148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
11 Bogdanos DP, Smyk DS, Invernizzi P, Rigopoulou EI, Blank M, Sakkas L, Pouria S, Shoenfeld Y. Tracing environmental markers of autoimmunity: introducing the infectome. Immunol Res 2013;56:220-40. [PMID: 23592050 DOI: 10.1007/s12026-013-8399-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
12 Liu Y, Meyer C, Xu C, Weng H, Hellerbrand C, ten Dijke P, Dooley S. Animal models of chronic liver diseases. Am J Physiol Gastrointest Liver Physiol. 2013;304:G449-G468. [PMID: 23275613 DOI: 10.1152/ajpgi.00199.2012] [Cited by in Crossref: 138] [Cited by in F6Publishing: 120] [Article Influence: 13.8] [Reference Citation Analysis]
13 Bogdanos DP, Smyk DS, Invernizzi P, Rigopoulou EI, Blank M, Pouria S, Shoenfeld Y. Infectome: a platform to trace infectious triggers of autoimmunity. Autoimmun Rev. 2013;12:726-740. [PMID: 23266520 DOI: 10.1016/j.autrev.2012.12.005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
14 Al-Harthy N, Kumagi T. Natural history and management of primary biliary cirrhosis. Hepat Med. 2012;4:61-71. [PMID: 24367233 DOI: 10.2147/HMER.S25998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.2] [Reference Citation Analysis]
15 Folseraas T, Melum E, Franke A, Karlsen TH. Genetics in primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol. 2011;25:713-726. [PMID: 22117637 DOI: 10.1016/j.bpg.2011.09.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
16 Concepcion AR, Medina JF. Approaches to the pathogenesis of primary biliary cirrhosis through animal models. Clin Res Hepatol Gastroenterol 2012;36:21-8. [PMID: 21862437 DOI: 10.1016/j.clinre.2011.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
17 Smyk DS, Mytilinaiou MG, Milkiewicz P, Rigopoulou EI, Invernizzi P, Bogdanos DP. Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22. Auto Immun Highlights 2012;3:1-9. [PMID: 26000122 DOI: 10.1007/s13317-011-0023-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
18 Tsuneyama K, Moritoki Y, Kikuchi K, Nakanuma Y. Pathological features of new animal models for primary biliary cirrhosis. Int J Hepatol 2012;2012:403954. [PMID: 21994883 DOI: 10.1155/2012/403954] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wu SJ, Yang YH, Tsuneyama K, Leung PS, Illarionov P, Gershwin ME, Chuang YH. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology 2011;53:915-25. [PMID: 21374662 DOI: 10.1002/hep.24113] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 6.2] [Reference Citation Analysis]
20 Poupon R. Primary biliary cirrhosis: A 2010 update. Journal of Hepatology 2010;52:745-58. [DOI: 10.1016/j.jhep.2009.11.027] [Cited by in Crossref: 195] [Cited by in F6Publishing: 167] [Article Influence: 16.3] [Reference Citation Analysis]
21 Invernizzi P, Selmi C, Gershwin ME. Update on primary biliary cirrhosis. Dig Liver Dis. 2010;42:401-408. [PMID: 20359968 DOI: 10.1016/j.dld.2010.02.014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
22 Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun. 2010;34:J300-J306. [PMID: 20036105 DOI: 10.1016/j.jaut.2009.12.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 5.1] [Reference Citation Analysis]
23 Lohse AW, Weiler-Normann C, Tiegs G. Immune-mediated liver injury. J Hepatol. 2010;52:136-144. [PMID: 19913936 DOI: 10.1016/j.jhep.2009.10.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
24 Zhang W, Sharma R, Ju ST, He XS, Tao Y, Tsuneyama K, Tian Z, Lian ZX, Fu SM, Gershwin ME. Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis. Hepatology 2009;49:545-52. [PMID: 19065675 DOI: 10.1002/hep.22651] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
25 Fickert P, Trauner M. When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosis. J Hepatol 2009;50:633-5. [PMID: 19157624 DOI: 10.1016/j.jhep.2008.12.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
26 Jones DE, Palmer JM, Burt AD, Kirby JA. The specificity of liver inflammation in mouse models of primary biliary cirrhosis. Hepatology 2008;48:1353-4; author reply 1354-5. [PMID: 18792128 DOI: 10.1002/hep.22522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]